Earnings call transcript: LightPath Technologies Q4 2025 sees revenue growth but EPS miss

LightPath Technologies reported Q4 2025 revenue of $12.2 million, exceeding forecasts with a 41.4% year-over-year increase, but posted a significant EPS miss with a loss of $0.16 against an expected loss of $0.03, causing a 5.25% after-hours stock drop. Despite the immediate profitability challenge, the company emphasized a record $90 million backlog, propelled by a strategic pivot to infrared imaging subsystems utilizing its proprietary BlackDiamond glass as a germanium alternative, securing substantial new orders in border surveillance and counter-UAS. This strategic shift, supported by an $8 million investment and an outlook for 35-40% gross margins and positive adjusted EBITDA in fiscal 2026, positions LPTH for significant future growth despite current operational hurdles.

Analysis

LightPath Technologies' (LPTH) Q4 2025 earnings report presents a company in a critical strategic transition, marked by strong top-line momentum but near-term profitability pressures. Revenue grew an impressive 41.4% year-over-year to $12.2 million, surpassing the $11.9 million forecast. However, this was overshadowed by a significant earnings miss, with a loss per share of $0.16 against an expected loss of $0.03, which triggered a 5.25% after-hours stock decline. This dichotomy reflects the costs of its strategic pivot away from commoditized components; gross margin compressed to 22% due to a $0.5 million inventory charge, while operating expenses rose 52%, driven by the integration of the recently acquired G5 Infrared. The more compelling forward-looking narrative is the company's record $90 million backlog, a more than four-fold increase driven by its successful shift into higher-value infrared subsystems. This strategy capitalizes on geopolitical tailwinds, as China's export restrictions on germanium have increased demand for LightPath’s proprietary, germanium-alternative BlackDiamond glass, securing a $40 million order for border surveillance and over $10 million in orders for counter-UAS systems. Management's optimistic guidance for fiscal 2026, which anticipates gross margin expansion to 35-40% and a return to positive adjusted EBITDA, suggests the current bottom-line weakness is a transitional cost for substantial future growth.

Key Decisions for Investors

• Investors should look beyond the headline Q4 EPS miss and focus on the execution of the strategic pivot, as evidenced by the record $90 million backlog and management's explicit guidance for gross margin expansion to 35-40% in fiscal 2026.
• The primary catalyst to monitor is the contract award decision for the NGSRI program with Lockheed Martin, as a win represents a transformative event with a potential annual revenue impact of $50-$100 million.
• While the growth narrative is compelling, it is prudent to weigh the execution risks of scaling production and integrating G5 Infrared against the stock's high price-to-book ratio of 17.8x, which indicates significant future growth is already priced in.